Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease

We describe our experience with a juvenile patient who had refractory intestinal Behcet's disease that responded to adalimumab, a fully humanized antibody against soluble TNF-α and its receptor. The patient, a 13-year-old girl, presented with oral aphthous ulcers, vulvar pain, and rashes on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaji, Mariko, Kishi, Takayuki, Miyamae, Takako, Nagata, Satoru, Yamanaka, Hisashi, Fujikawa, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644826/
https://www.ncbi.nlm.nih.gov/pubmed/26609459
http://dx.doi.org/10.1155/2015/716138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644826/
https://www.ncbi.nlm.nih.gov/pubmed/26609459
http://dx.doi.org/10.1155/2015/716138

Ejemplares similares